137 related articles for article (PubMed ID: 37541588)
1. Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases.
Chaudhary P; Proulx J; Park IW
Virus Res; 2023 Oct; 335():199191. PubMed ID: 37541588
[TBL] [Abstract][Full Text] [Related]
2. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
LaSalle JM; Reiter LT; Chamberlain SJ
Epigenomics; 2015 Oct; 7(7):1213-28. PubMed ID: 26585570
[TBL] [Abstract][Full Text] [Related]
4. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily.
Nawaz Z; Lonard DM; Smith CL; Lev-Lehman E; Tsai SY; Tsai MJ; O'Malley BW
Mol Cell Biol; 1999 Feb; 19(2):1182-9. PubMed ID: 9891052
[TBL] [Abstract][Full Text] [Related]
5. Towards an understanding of Angelman syndrome in mice studies.
Yang X
J Neurosci Res; 2020 Jun; 98(6):1162-1173. PubMed ID: 31867793
[TBL] [Abstract][Full Text] [Related]
6. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome.
Matsuura T; Sutcliffe JS; Fang P; Galjaard RJ; Jiang YH; Benton CS; Rommens JM; Beaudet AL
Nat Genet; 1997 Jan; 15(1):74-7. PubMed ID: 8988172
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Impairment via UBE3A and HIV-1 Nef Interactions Utilizing the Ubiquitin Proteasome System.
Pyeon D; Rojas VK; Price L; Kim S; Meharvan S; Park IW
Viruses; 2019 Nov; 11(12):. PubMed ID: 31783587
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.
Low D; Chen KS
Eur J Hum Genet; 2010 Nov; 18(11):1228-35. PubMed ID: 20571502
[TBL] [Abstract][Full Text] [Related]
9. Angelman syndrome-associated point mutations in the Zn
Kühnle S; Martínez-Noël G; Leclere F; Hayes SD; Harper JW; Howley PM
J Biol Chem; 2018 Nov; 293(47):18387-18399. PubMed ID: 30257870
[TBL] [Abstract][Full Text] [Related]
10. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons.
Albrecht U; Sutcliffe JS; Cattanach BM; Beechey CV; Armstrong D; Eichele G; Beaudet AL
Nat Genet; 1997 Sep; 17(1):75-8. PubMed ID: 9288101
[TBL] [Abstract][Full Text] [Related]
11. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes.
Mabb AM; Judson MC; Zylka MJ; Philpot BD
Trends Neurosci; 2011 Jun; 34(6):293-303. PubMed ID: 21592595
[TBL] [Abstract][Full Text] [Related]
12. HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.
Wang T; Wang J; Wang J; Mao L; Tang B; Vanderklish PW; Liao X; Xiong ZQ; Liao L
Neurobiol Dis; 2019 Dec; 132():104585. PubMed ID: 31445164
[TBL] [Abstract][Full Text] [Related]
13. Angelman Syndrome Due to UBE3A Gene Mutation.
Goswami JN; Sahu JK; Singhi P
Indian J Pediatr; 2018 May; 85(5):390-391. PubMed ID: 29250725
[TBL] [Abstract][Full Text] [Related]
14. Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome.
Godavarthi SK; Dey P; Maheshwari M; Jana NR
Hum Mol Genet; 2012 Apr; 21(8):1824-34. PubMed ID: 22215440
[TBL] [Abstract][Full Text] [Related]
15. Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila.
Li W; Yao A; Zhi H; Kaur K; Zhu YC; Jia M; Zhao H; Wang Q; Jin S; Zhao G; Xiong ZQ; Zhang YQ
PLoS Genet; 2016 May; 12(5):e1006062. PubMed ID: 27232889
[TBL] [Abstract][Full Text] [Related]
16. Angelman syndrome scientific symposium on the structure and function of UBE3A/E6AP.
Williams C
J Child Neurol; 2009 Jul; 24(7):904-8. PubMed ID: 19617463
[TBL] [Abstract][Full Text] [Related]
17. Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome.
Berg EL; Pride MC; Petkova SP; Lee RD; Copping NA; Shen Y; Adhikari A; Fenton TA; Pedersen LR; Noakes LS; Nieman BJ; Lerch JP; Harris S; Born HA; Peters MM; Deng P; Cameron DL; Fink KD; Beitnere U; O'Geen H; Anderson AE; Dindot SV; Nash KR; Weeber EJ; Wöhr M; Ellegood J; Segal DJ; Silverman JL
Transl Psychiatry; 2020 Jan; 10(1):39. PubMed ID: 32066685
[TBL] [Abstract][Full Text] [Related]
18. Imprinted expression of UBE3A in non-neuronal cells from a Prader-Willi syndrome patient with an atypical deletion.
Martins-Taylor K; Hsiao JS; Chen PF; Glatt-Deeley H; De Smith AJ; Blakemore AI; Lalande M; Chamberlain SJ
Hum Mol Genet; 2014 May; 23(9):2364-73. PubMed ID: 24363065
[TBL] [Abstract][Full Text] [Related]
19. A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome.
Geerts-Haages A; Bossuyt SNV; den Besten I; Bruggenwirth H; van der Burgt I; Yntema HG; Punt AM; Brooks A; Elgersma Y; Distel B; Valstar M
Mol Genet Genomic Med; 2020 Nov; 8(11):e1481. PubMed ID: 32889787
[TBL] [Abstract][Full Text] [Related]
20. An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A.
Yi JJ; Berrios J; Newbern JM; Snider WD; Philpot BD; Hahn KM; Zylka MJ
Cell; 2015 Aug; 162(4):795-807. PubMed ID: 26255772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
